Amneal Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
| Przychód (średnia) |
2,770.00 |
3,011.04 |
3,233.70 |
3,504.68 |
3,931.74 |
| Przychód Δ r/r |
0.00% |
8.70% |
7.39% |
8.38% |
12.19% |
| Przychód (min) |
2,730.45 |
2,979.79 |
3,133.43 |
3,504.68 |
3,875.61 |
| Przychód (max) |
2,812.36 |
3,083.97 |
3,303.24 |
3,504.69 |
3,991.86 |
| EBITDA (średnia) |
419.62 |
456.13 |
489.86 |
530.91 |
595.61 |
| EBIT (średnia) |
132.34 |
143.86 |
154.49 |
167.44 |
187.84 |
| EBIT % |
4.78% |
4.78% |
4.78% |
4.78% |
4.78% |
| Zysk netto (średni) |
189.58 |
220.15 |
251.55 |
316.19 |
296.62 |
| Zysk netto % |
6.84% |
7.31% |
7.78% |
9.02% |
7.54% |
| EPS (średnia) |
0.61 |
0.71 |
0.82 |
1.02 |
0.96 |
| Liczba analityków (Przychody) |
3 |
2 |
4 |
3 |
1 |
| Liczba analityków (EPS) |
2 |
3 |
2 |
1 |
1 |
| symbol |
AMRX |
AMRX |
AMRX |
AMRX |
AMRX |